Polymer Surface Treatments for Drug Delivery and Wound Healing
Source abstract
Abstract
Nanomedicine is a cutting-edge field at the intersection of nanotechnology and medicine that has experienced significant advancements in recent decades [...]
Only a short abstract or summary was supplied by the source.
Source: crossref · Quality: short
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
References (28)
Show source-provided references
1. Enhancing cancer immunotherapy with nanomedicine10.1038/s41577-019-0269-6 ↗
2. Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: A review of mechanistic approaches for cancer treatment10.1080/10717544.2022.2144541 ↗
3. Cancer nanomedicine10.1038/s41568-022-00496-9 ↗
4. Polymeric particle-based therapies for acute inflammatory diseases10.1038/s41578-022-00458-5 ↗
5. Zielińska, A., Carreiró, F., Oliveira, A.M., Neves, A., Pires, B., Venkatesh, D.N., Durazzo, A., Lucarini, M., Eder, P., and Silva, A.M. (2020). Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules, 25.10.3390/molecules25163731 ↗
6. Lipid-based nanoparticle technologies for liver targeting
7. Lipid-based nanoparticle formulations for small molecules and RNA drugs10.1080/17425247.2019.1669558 ↗
8. Gold nanoparticle-mediated bubbles in cancer nanotechnology10.1016/j.jconrel.2020.12.022 ↗
9. Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review10.1016/j.ijbiomac.2021.10.142 ↗
10. Masse, F., Desjardins, P., Ouellette, M., Couture, C., Omar, M.M., Pernet, V., Guérin, S., and Boisselier, E. (2019). Synthesis of Ultrastable Gold Nanoparticles as a New Drug Delivery System. Molecules, 24.10.3390/molecules24162929 ↗
11. Temperature-Responsive Nanoassemblies for Self-Regulated Photothermal Therapy and Controlled Copper Release to Accelerate Chronic Wound Healing10.1021/acsabm.3c00267 ↗
12. Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer10.1080/21655979.2021.1971507 ↗
13. A hybrid hydrogel constructed using drug loaded mesoporous silica and multiple response copolymer as an intelligent dressing for wound healing of diabetic foot ulcers10.1039/D3TB00395G ↗
14. Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery10.1021/acsomega.2c05976 ↗
15. Surface modification and local orientations of surface molecules in nanotherapeutics10.1016/j.jconrel.2015.04.017 ↗
16. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer
17. Functionalized mesoporous silica nanoparticles in anticancer therapeutics10.1016/j.semcancer.2019.08.022 ↗
18. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers10.2147/IJN.S156616 ↗
19. Stimuli-responsive nanocarriers for therapeutic applications in cancer10.20892/j.issn.2095-3941.2020.0496 ↗
20. Intranasal delivery of polymer-anchored lipid nanoconstructs of artemether-lumefantrine in Plasmodium berghei ANKA murine model10.1016/j.jddst.2020.102114 ↗
21. Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis10.1016/j.ijpharm.2017.11.071 ↗
22. Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer’s disease: A preclinical evidence10.1016/j.colsurfb.2021.111838 ↗
23. Glycol chitosan functionalized asenapine nanostructured lipid carriers for targeted brain delivery: Pharmacokinetic and teratogenic assessment10.1016/j.ijbiomac.2017.11.031 ↗
24. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles10.1016/j.ejpb.2018.02.010 ↗
25. Surface Modification of Biomedically Essential Nanoparticles Employing Polymer Coating10.1007/978-1-4939-9516-5_13 ↗
26. Safety Considerations of Cancer Nanomedicine—A Key Step toward Translation10.1002/smll.202000673 ↗
27. Nanomedicine to overcome antimicrobial resistance: Challenges and prospects10.2217/nnm-2023-0022 ↗
28. Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals10.1016/j.addr.2020.07.024 ↗